PEGASUS™ is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. Surrogate assays ...
In observance of the 100th anniversary of the bombing of the Los Angeles Times, reporter Lew Irwin wrote in Oct. 3, 2010, editions: Shortly after 1 a.m. on Oct. 1, 1910, 100 years ago Friday, a time ...
1910 is on a mission to “make undruggable targets a thing of the past” by “turning every pharma company into an AI company,” says founder and CEO, Jen Asher, PhD. The Sam Altman–backed AI drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results